Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Toward proof of concept of a one health approach to disease prediction and control
Indexado
Scopus SCOPUS_ID:84888324117
DOI 10.3201/EID1912.130265
Año 2013
Tipo

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



A One Health approach considers the role of changing environments with regard to infectious and chronic disease risks affecting humans and nonhuman animals. Recent disease emergence events have lent support to a One Health approach. In 2010, the Stone Mountain Working Group on One Health Proof of Concept assembled and evaluated the evidence regarding proof of concept of the One Health approach to disease prediction and control. Aspects examined included the feasibility of integrating human, animal, and environmental health and whether such integration could improve disease prediction and control efforts. They found evidence to support each of these concepts but also identified the need for greater incorporation of environmental and ecosystem factors into disease assessments and interventions. The findings of the Working Group argue for larger controlled studies to evaluate the comparative effectiveness of the One Health approach. Recent global disease events have highlighted the increasing effects of zoonotic (transmitted from animals to humans) pathogens on human and animal health (1). It has also become evident that changes in the environment, including agricultural intensification, population growth, climate change, and human encroachment into wildlife habitats, are drivers for such zoonotic disease emergence (2,3) and that environmental contamination with toxic chemicals and other hazards threaten human and animal populations (4). The One Health approach emphasizes the relatedness of human, animal, and environmental health (5) and the importance of transdisciplinary efforts (6). The One Health approach has been recognized as a major element of disease control and prevention strategies by international agencies, including the Food and Agriculture Organization of the United Nations, the World Organisation for Animal Health, and the World Health Organization (www.who.int/influenza/resources/documents/tripartite_concept_note_hanoi/en/index.html) and by national agencies and professional groups across multiple disciplines in several countries (www.onehealthinitiative.com/supporters.php). As with any paradigm, there is a need to explore and document the comparative effectiveness of the One Health approach over conventional approaches to disease prevention and control. A recent Institute of Medicine report on microbial threats to global food safety called for "research prototypes for proof of concept validation of One Health principles as applied to food safety in the developing world, and also to public-private partnerships between government and the food industry" (7), and a US-Mexico border One Health coalition has recommended a "proof of concept project to validate a One Health approach in preparedness and response to external stakeholders" (www.oneborderonehealth.com). In the biomedical context, "proof of concept" describes evidence that a particular drug, device, treatment method, or other approach is feasible, effective, and provides added value over existing approaches. Often a proof of concept study is a pilot clinical trial that helps determine whether larger, more definitive studies are indicated. Although this proof of concept model is typical of the investigation of a new drug (8), similar methods have been used to assess the proof of concept of novel teaching methods for physicians (9), mind-body techniques for stress reduction (10), and intersectoral collaboration between health services and fire departments to prevent elderly persons from falling (11).

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Infectious Diseases
Immunology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Rabinowitz, Peter M. Hombre Yale School of Medicine - Estados Unidos
University of Washington, Seattle - Estados Unidos
University of Washington - Estados Unidos
2 Kock, Richard Hombre University of London - Reino Unido
3 Kachani, Malika Mujer Western University of Health Sciences - Estados Unidos
4 Kunkel, Rebekah Mujer Centers for Disease Control and Prevention - Estados Unidos
5 Thomas, Jason Hombre Centers for Disease Control and Prevention - Estados Unidos
6 Gilbert, Jeffrey Hombre International Livestock Research Institute - Laos
7 Wallace, Robert Hombre University of Minnesota - Estados Unidos
University of Minnesota Twin Cities - Estados Unidos
8 Blackmore, Carina Mujer Florida Dept. Hlth. R. - Estados Unidos
9 Wong, David Hombre US National Park Service - Estados Unidos
10 Karesh, William Hombre EcoHealth Alliance - Estados Unidos
11 Natterson, Barbara Mujer Ronald Reagan UCLA Medical Center - Estados Unidos
12 Dugas, Raymond Hombre Pan American Health Organization - Chile
13 Rubin, Carol Mujer Centers for Disease Control and Prevention - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Sin Información

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Sin Información

Muestra la fuente de financiamiento declarada en la publicación.